Literature DB >> 22787186

A reversible cerebral vasoconstriction syndrome.

Fang Ba1, Fabrizio Giuliani, Richard Camicioli, Maher Saqqur.   

Abstract

Reversible cerebral vasoconstriction syndrome (RCVS) is typically presented with severe headaches where, vascular imaging demonstrates multiple intracranial arterial narrowing. Variable triggers are related to RCVS, such as serotonin agents and bromocriptine. Thus, a detailed medication history is important. Subarachnoid haemorrhage (SAH) is not uncommon in RCVS. Repeat vascular imaging at 2-3 months with complete reversal of the narrowed vessels confirms the diagnosis of RCVS. The authors present a case where use of triptan along with multiple psychotropic medications, was associated with RVCS. Neuroimaging demonstrated focal SAH and diffuse beaded appearance involving the intracranial vasculature. The patient improved clinically with oral nimodipine treatment. Repeat angiography and a follow-up transcranial Doppler showed complete resolution of vasoconstriction. In the setting of acute severe headache, with any 'red flags', it is important to evaluate the medication use and other precipitating risks for RVCS. Vascular imaging is the key for diagnosis.

Entities:  

Mesh:

Year:  2012        PMID: 22787186      PMCID: PMC3417010          DOI: 10.1136/bcr.09.2011.4841

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Benign cerebral angiopathy; postpartum cerebral angiopathy: characteristics and treatment.

Authors:  Sofia Calado; Miguel Viana-Baptista
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-05

2.  Cerebral vasospasm from sumatriptan.

Authors:  S Dash; O Bogdanova; A Xavier; J Farkas; P Pullicino
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

Review 3.  Narrative review: reversible cerebral vasoconstriction syndromes.

Authors:  Leonard H Calabrese; David W Dodick; Todd J Schwedt; Aneesh B Singhal
Journal:  Ann Intern Med       Date:  2007-01-02       Impact factor: 25.391

Review 4.  Reversible cerebral segmental vasoconstriction.

Authors:  G K Call; M C Fleming; S Sealfon; H Levine; J P Kistler; C M Fisher
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

5.  Magnetic resonance angiography in reversible cerebral vasoconstriction syndromes.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Shuu-Jiun Wang; Feng-Chi Chang; Jiing-Feng Lirng; Ying-Chen Fang; Ben-Chang Shia; Jaw-Ching Wu
Journal:  Ann Neurol       Date:  2010-05       Impact factor: 10.422

6.  Recurrent primary thunderclap headache and benign CNS angiopathy: spectra of the same disorder?

Authors:  S-P Chen; J-L Fuh; J-F Lirng; F-C Chang; S-J Wang
Journal:  Neurology       Date:  2006-12-26       Impact factor: 9.910

7.  Cerebral vasoconstriction and stroke after use of serotonergic drugs.

Authors:  A B Singhal; V S Caviness; A F Begleiter; E J Mark; G Rordorf; W J Koroshetz
Journal:  Neurology       Date:  2002-01-08       Impact factor: 9.910

8.  Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect.

Authors:  Lars Edvinsson; Erik Uddman; Angelica Wackenfors; Anthony Davenport; Jenny Longmore; Malin Malmsjö
Journal:  Clin Sci (Lond)       Date:  2005-09       Impact factor: 6.124

9.  The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients.

Authors:  Anne Ducros; Monique Boukobza; Raphaël Porcher; Mariana Sarov; Dominique Valade; Marie-Germaine Bousser
Journal:  Brain       Date:  2007-11-19       Impact factor: 13.501

10.  Transcranial color doppler study for reversible cerebral vasoconstriction syndromes.

Authors:  Shih-Pin Chen; Jong-Ling Fuh; Feng-Chi Chang; Jiing-Feng Lirng; Ben-Chang Shia; Shuu-Jiun Wang
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

View more
  2 in total

Review 1.  Triptan-induced Reversible Cerebral Vasoconstriction Syndrome: Two Case Reports with a Literature Review.

Authors:  Yuji Kato; Takeshi Hayashi; Satoko Mizuno; Yohsuke Horiuchi; Masayuki Ohira; Norio Tanahashi; Masaki Takao
Journal:  Intern Med       Date:  2016-12-01       Impact factor: 1.271

2.  Putative role of prostaglandin receptor in intracerebral hemorrhage.

Authors:  Shekher Mohan; Abdullah S Ahmad; Alexander V Glushakov; Chase Chambers; Sylvain Doré
Journal:  Front Neurol       Date:  2012-10-22       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.